Tech Center 1600 • Art Units: 1623 1673 1693
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19346873 | MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 17799393 | METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS | Non-Final OA | Ohio State Innovation Foundation |
| 18744247 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | Non-Final OA | OTSUKA PHARMACEUTICAL CO., LTD. |
| 17550271 | LONG STOKES SHIFT CHROMENOQUINOLINE DYES AND USES IN SEQUENCING APPLICATIONS | Final Rejection | Illumina Cambridge Limited |
| 18560242 | COMBINATION THERAPIES | Non-Final OA | Janssen Pharmaceutica NV |
| 18258731 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | Non-Final OA | The Research Foundation for The State University of New York |
| 18321563 | Pet Food Compositions | Non-Final OA | Hill's Pet Nutrition, Inc. |
| 18495216 | NONWOVEN GLUCAN WEBS | Non-Final OA | NUTRITION & BIOSCIENCES USA 4, INC. |
| 18739149 | NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS | Final Rejection | Atea Pharmaceuticals, Inc. |
| 18252394 | MODIFIED SOPHOROLIPID FOR IMPROVED BIOAVAILABILITY OF AMINO ACIDS AND METHOD OF USE | Final Rejection | LOCUS SOLUTIONS IPCO, LLC |
| 18571137 | PHARMACEUTICAL COMPOSITION FOR INCREASING MITOCHONDRIAL ACTIVITY AND/OR IMPROVING ADIPONECTIN PRODUCTION | Non-Final OA | LOGICK ENERGETICS B.V. |
| 18386643 | PURIFICATION METHOD FOR SUCRALOSE-6-ETHYL ESTER | Non-Final OA | ANHUI JINHE INDUSTRIAL CO., LTD. |
| 18483622 | BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDES | Non-Final OA | Conagen Inc. |
| 18477929 | HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE | Non-Final OA | Teon Therapeutics, Inc. |
| 18477946 | HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE | Non-Final OA | Teon Therapeutics, Inc. |
| 17844407 | BIVALENT COMPOUNDS, CONJUGATES AND USES THEREOF | Final Rejection | RISEN (SUZHOU) PHARMA TECH CO., LTD. |
| 18281211 | HEMOSTATIC MATERIAL | Non-Final OA | ARTISAN LAB CO., LTD. |
| 18280527 | 3'3' CYCLIC DINUCLEOTIDES CONTAINING ISONUCLEOTIDIC UNITS | Non-Final OA | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR, V. V. I. |
| 18279150 | GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Non-Final OA | DONGGUAN HEC CORDYCEPS R&D CO., LTD. |
| 18022855 | PROCESS FOR THE DIRECT CONVERSION OF CELLULOSE TO GLYCOLS USING NON-NOBLE METAL LOADED ZEOLITE CATALYSTS | Non-Final OA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH |
| 18323272 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF | Non-Final OA | SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. |
| 17429113 | COMPOSITION FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION | Non-Final OA | SAN-EI GEN F.F.I., INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy